SEC Form 4 · accession 0001274644-15-000033
Ocera Therapeutics, Inc. · OCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Byrnes
Officer — CFO and Treasurer
Period of report
May 6, 2015
Accepted (ET)
May 6, 2015 · 6:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001274644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 6, 2015 | P | 2,500 | $3.61 | A | 6,500 | D |
Table II — derivative securities
No Table II lines on this filing.